Protease inhibitors and blood sugar problems.
D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001786:Blood Glucose / Q000378:metabolism*; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D019469:Indinavir / Q000009:adverse effects / Q000627:therapeutic use; D007328:Insulin / Q000097:blood; D019888:Nelfinavir / Q000009:adverse effects / Q000627:therapeutic use
D019380:Anti-HIV Agents; D001786:Blood Glucose; D017320:HIV Protease Inhibitors; D007328:Insulin; D019469:Indinavir; D019888:Nelfinavir